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ABSTRACT

Albers, Renee Elizabeth. M.S., Microbiology and Immunology Program, Wright State
University, 2013. Hypoxia Inducible Factor 1 Alpha (HIF-1α): A Major Regulator of
Placental Development.

Hypoxia-inducible factor-1 alpha (HIF-1α) is a critical component of the cellular
oxygen-sensing machinery and is essential for placental formation and embryonic
survival. In this study, we promoted prolonged expression of HIF-1α, by using a form
that is insensitive to oxygen, denoted as CA-HIF-1α. In order to have continual placental
specific expression of the CA-HIF-1α, lentiviral infection was performed on embryos at
the blastocyst stage of development and transferred into pseudo-pregnant mothers.
Placental analysis was performed via in situ hybridization on embryonic day 14.5 (E14.5)
to determine the effects of CA-HIF-1α prolonged expression. Data indicate that
prolonged activity of CA-HIF-1α restricted to trophoblast cells in the mouse placenta
results in the inability of cells to advance from their progenitor states, failure of the
placenta to organize properly, and failure of trophoblasts to remodel the maternal arteries.
Since HIF-1α has the ability to cause developmental placental disruption, its regulation in
the placenta could be key in multiple pregnancy-associated disorders such as preeclampsia and intrauterine growth restriction (IUGR).

iii	
  

TABLE OF CONTENTS
I. INTRODUCTION ........................................................................................................... 1
Placental importance ....................................................................................................... 1
Pre-eclampsia .................................................................................................................. 1
Placental specific gene transfer ....................................................................................... 2
Placental organization ..................................................................................................... 2
Placental oxygen and development ................................................................................. 8
Hypoxia inducible factor 1 alpha (HIF-1α) ..................................................................... 8
HIF-1α related gene knock-out ..................................................................................... 11
Summary ....................................................................................................................... 14

II. MATERIALS AND METHODS ................................................................................. 16
Materials ........................................................................................................................ 16
Cloning and Cell Culture............................................................................................... 16
Western blotting (Kashmira Kulkarni unpublished methods)....................................... 17
Luciferase assay (Kashmira Kulkarni unpulblished methods) ...................................... 19
Lentiviral production ..................................................................................................... 19
Lentiviral concentration and titering ............................................................................. 20
Blastocyst Isolation and Culture ................................................................................... 20
Blastocysts infection ..................................................................................................... 21
Embryo transfer ............................................................................................................. 22

iv	
  

Immunocytochemistry (Kashmira Kulkarni unpulblished methods) ............................ 22
Probes ............................................................................................................................ 23
Tissue preparation and in situ hybridization ................................................................. 24
Animal use..................................................................................................................... 28

III. RESULTS ................................................................................................................... 29
Placental specific expression ......................................................................................... 29
HIF-1α prolonged expression ........................................................................................ 36
Inhibition of differentiation ........................................................................................... 39
Decrease in branching morphogenesis .......................................................................... 44
Placental disorganization............................................................................................... 44
Decrease in maternal artery remodeling........................................................................ 49

IV. DISCUSSION ............................................................................................................. 53
Altered Morphology ...................................................................................................... 53
Maternal artery remodeling ........................................................................................... 54
Future studies ................................................................................................................ 55

V. APPENDIX .................................................................................................................. 57
Abbreviations ................................................................................................................ 57

VI. REFERENCES ........................................................................................................... 60

v	
  

LIST OF FIGURES
Figure 1. Blastocyst organization. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

Figure 2. Organization of the rodent placenta. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Figure 3. HIF-1α activation and inactivation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10

Figure 4. Oxygen insensitive form of HIF-1α, CA- HIF-1α, is always active . . . . . . . . 12

Figure 5. Diagram of a riboprobe. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25

Figure 6. Trophoblast specific GFP expression after infection with Lv-CMV-GFP-V5 at
the blastocyst stage. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30

Figure 7. Analysis for placental specific expression of the GFP at E10.5 after infection
with Lv-CMV-GFP-V5 at the blastocyst (E3.5) stage of development. . . . . . . . . . . . . . 32

Figure 8. Immunohistochemical analysis of V5 epitope tag expression in placenta
infected with Lv-CMV-GFP-V5 virus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

vi	
  

Figure 9. HIF-1α3XSDM gene was cloned into lentiviral vector and in situ hybridization
analysis for prolonged expression of HIF-1α. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

Figure 10. Prolonged HIF-1α gene expression does not affect fetal or placental weight at
E14.5 stage in development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

Figure 11. Prolonged HIF-1α gene expression inhibits placental cells from progressing
past their progenitor states. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .42

Figure 12. Prolonged HIF-1α gene expression decreases branching morphogenesis. . . .45

Figure 13. Prolonged HIF-1α gene expression decreases placental organization. . . . . . .47

Figure 14. Prolonged HIF-1α gene expression prevents maternal artery remodeling. . . .50

	
  
vii

LIST OF TABLES
Table 1. Genes surveyed by in situ hybridization. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

	
  
viii

ACKNOWLEDGEMENTS
There are many people that I would like to thank and acknowledge for making
this work possible. First, I would like to thank Dr. Thomas L. Brown for allowing me
into his lab as an undergraduate student, and then allowing me to continue my graduate
work here. I know that taking on undergraduate students can be costly both in terms of
time and finances, but I am glad Dr. Brown was willing to take that risk because it was
the work in his lab that made me want to pursue a career in research. I would also like to
thank Dr. Brown for his guidance and support while working on this project. I would
also like to thank my committee members, Dr. Brown, Dr. Christopher Wyatt, and Dr.
Courtney Sulentic, for their guidance throughout my project.
I would like to thank the current and former members of the Brown lab for all
their help, company, laughs, and great food during lab meetings: Chanel Keoni, Melissa
Kaufman, Larissa Tangeman, Erica Baker, Savannah Doliboa, Rebecca Bricker, Cody
Saylor, Deanne Jacobs, Elizabeth Ludvigson, Samantha Venkatesh, Kirsten Jacobson,
Mary Mick, and all the other students that have helped with my project. I would
especially like to thank Melissa Kaufman and Larissa Tangeman. Melissa has been so
helpful in teaching me how to work with the animals. She has been wonderful to work
with and her ability to schedule and plan has been much appreciated. I will always be
grateful to Larissa who recruited me to the Brown lab when she was my teaching
assistant.
I would like to thank Natale Lab from University of Calgary in Canada for their
work with the in situ hybridizations. Dr. David Natale has been helpful in my

ix	
  

understanding and interpreting the in situ hybridizations. I would like to especially thank
Byrony Natale and Martha Hughes of the Natale Lab for their work on the in situ
hybridizations. I would like to thank Dr. Gomez-Cambronero and Dr. Courtney Sulentic
for use of their laboratory equipment. I would like to thank the L.A.R. staff for all of
their help when working on this project. I would also like to thank the Wyatt Lab for
being such wonderful lab neighbors.
I would like to thank the Microbiology and Immunology Program for providing
me with financial support in the form of a teaching assistantship. I really enjoyed
working with students, and this assistantship allowed me to realize the joy that comes
from helping others to learn in the science field. I would also like to thank lecturer
Meredith Rodgers and the other teaching assistants that I got the opportunity to work
with.
Finally, I would like to thank my family and friends for their love and support
through this project. I would especially like to thank anyone who listened to me
excitedly explain my research to them even though they were not nearly as excited as I
was.

x	
  

I. INTRODUCTION
Placental importance
The placenta is an essential transient organ that is formed during mammalian
pregnancy. This highly organized organ allows for transport of nutrients and wastes
between the mother and the developing fetus. In order to maintain a healthy pregnancy,
the placenta needs to remodel maternal arteries to facilitate blood flow. Loss of the
placental organization or ability to remodel maternal arteries leads to a reduction in
placental function and disorders such as pre-eclampsia [1-5].

Pre-eclampsia
Pre-eclampsia is a pregnancy related disorder that occurs in 5-7% of all births in
the United States and is a leading cause of maternal mortality in the world [2,6,7]. Some
of the characteristics of pre-eclampsia include maternal hypertension and proteinuria
during pregnancy, with these symptoms rapidly diminishing after delivery or termination
of the pregnancy [2,6,7]. Pre-eclampsia also leads to premature delivery and low birth
weight babies as well as the possibility of fetal death [2,6,7]. Placentas from preeclamptic pregnancies exhibit a lack of maternal artery invasion [2,6,7]. In normal
pregnancies, the maternal endothelial cells are replaced by invasive trophoblasts in a
process known as remodeling [8,9]. The process of maternal artery remodeling is
essential to establish appropriate blood flow and promote proper placental development
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[4,9]. Due to the placental defects associated with pre-eclampsia, it is important to study
placental development.

Placental specific gene transfer
The placenta is formed from a specific set of cells that arise during embryonic
development. The embryo progresses through may different stages of development after
fertilization, from the two-cell stage to the blastocyst, before implantation. At the
blastocyst stage of embryonic development, it is clear that there are two cell types [1012]. The first cell type at the blastocyst stage, which gives rise to the fetus, is known as
the inner cell mass (ICM) [10-12]. The second cell type that is apparent at the blastocyst
stage is the trophectoderm, and it develops into the placenta [10-12]. The trophectoderm
at the blastocyst stage consists of a single cell layer that surrounds the inner cell mass
(Figure 1). In order to obtain stable, placental-specific, expression of a gene, the preimplantation blastocyst can be infected with lentivirus containing the gene of interest [1113]. The blastocysts, with only its trophectoderm infected, can then be transferred into a
pseudo-pregnant female (foster mom) to facilitate the implantation of the embryo.
Blastocyst infection and then transfer into the pseudo-pregnant female allows for
infection of only the placenta but neither the mother nor the fetus, which is essential for
placental specific gene studies.

Placental organization
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Figure 4. Blastocyst organization.
The blastocyst consists of two cell types: the inner cell mass and trophectoderm. The
inner cell mass gives rise to the developing fetus (red). The trophectoderm is a single cell
layer forming the outside of the blastocysts that gives rise to the placenta (blue).

3	
  

Figure 1.

Inner Cell Mass
• Develops into fetus

Trophectoderm
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• Develops into placenta

The rodent placenta has analogous structure and function to the human placenta,
and has been used as a model system for human placental development [12,14,15]. The
rodent placenta consists of three cell lineages: the labrynthine, spongiotrophoblast, and
giant cell layers (Figure 2). The labrynthine layer is closest to the fetus and is important
in transport of nutrients and wastes between the mother and developing fetus [14]. One
of the markers used to identify the labrynthine cell lineage is Glial cell missing 1 (Gcm-1)
[16,17]. The spongiotrophoblast layer lies between the labrynthine and giant cell layers.
The spongiotrophoblast layer regulates exchange between the mother and fetus and acts
as a stem cell layer for the giant cells [12]. The marker used for the spongiotrophoblasts
layer is trophoblast specific protein alpha (Tpbpa/4311) [8]. The giant cell layer, which
is closest to the mother, is responsible for invasion and remodeling maternal arteries
during implantation [12]. The giant cell layer is identified by placental lactogen II (Pl2),
which identifies all non-invasive giant cells throughout placental development [18]. The
giant cell layer also has a cell subset, marked by proliferin (Plf), which is responsible for
invasion and remodeling of maternal arteries [18]. Other cells that are important to study
in order to understand placental organization include progenitors cells and glycogen cells.
Progenitor cells are marked by a transcription factor known as Mash2 (mammalian
achaete-scute homologous protein-2) [19,20]. Progenitor cell distribution is a helpful
indicator of the placenta’s developmental state since the overexpression of progenitor
cells indicates an underdeveloped or immature placenta [19,20]. Glycogen cells are
important for energy storage in the placenta and are positioned between the giant cell and
spongiotrophoblasts cell lineages [21,22].
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Figure 5. Organization of the rodent placenta.
The rodent placenta is organized into three cell lineages: giant cells, spongiotrophoblasts,
and labrynthine cells. Each cell type exhibits lineage-specific markers as indicated.
Figure modified from formerly published data [23].	
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Figure 2.

Three layers of trophoblast cells:
• Giant cell layer
• Invasion of maternal blood
vessels
• Lineage specific markers:
Pl2, Plf
• Spongiotrophoblast layer
• Regulation of exchange
and source of stem cells
• Lineage specific marker:
Tpbpa
• Labrynthine layer
• For nutrient transport
• Lineage specific marker:
Gcm-1
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Placental oxygen and development
	
  

Differing oxygen levels in the placenta have been implicated in playing an
important role in placental development. In the placenta, there is an oxygen gradient in
which conditions are very low, near 2% oxygen, during the early stages of development
and oxygen levels are near 12% at the maternal arteries [3,24]. During the early stages of
placental development when oxygen levels are low, trophoblast cell differentiation is
inhibited [25-29]. When trophoblast cells are exposed to higher oxygen concentrations
(10-20%), placental differentiation occurs [24,26]. One gene shown to be important in
placental cell differentiation is hypoxia-inducible factor 1 alpha (HIF-1α) [4,27,30,31].

Hypoxia inducible factor 1 alpha (HIF-1α)
	
  

HIF-1α is an oxygen-sensing gene in which protein levels are high when oxygen
levels are low [32-35]. HIF-1α protein expression is dependent on oxygen levels because
it has three sites that become hydroxylated in the presence of oxygen, causing it to be
inactive and signaling it toward proteasomal degradation [33,36,37]. The two proline
residues on HIF-1α are hydroxylated by prolyl hydroxylase domain proteins (PHD) and
the asparagine residue is hydroxylated by an asparaginyl hydroxylase known as factor
inhibiting HIF-1α (FIH) in the presence of oxygen [36,37]. Once hydroxylated by PHD,
the von Hippel-Lindau region of an E3 ligase recognizes HIF-1α and causes its
ubiquination, targeting HIF-1α toward proteasomal degradation [33,37] (Figure 3A). In
conditions with low oxygen, HIF-1α protein levels increase and HIF-1α translocates into
the nucleus, which allows for dimerization with the constitutively active HIF-1β subunit,
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Figure 6. HIF-1 activation and inactivation.
(A) Schematic of how HIF-1α is degraded in the presence of oxygen. (B) Schematic
showing how HIF-1α is active in low oxygen conditions and causes gene transcription.
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Figure 3.

A

Inactivation of HIF-1α in the presence of oxygen

B

Activation of HIF-1α under low oxygen
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also known as aryl hydrocarbon receptor nuclear translocator (ARNT) [37,38]. The
newly formed heterodimeric protein acts as a transcription factor, regulating genes
associated with cell survival, such as placental growth factor (PlGF), and angiogenesis,
such as vascular endothelial growth factor (VEGF) [27,33,34,39] (Figure 3B). Former
studies have shown that low levels of HIF-1α promote cell differentiation and high levels
of HIF-1α promote cell proliferation [27,33,40,41]. In order to create an oxygen
insensitive form of HIF-1α that would always promote cell proliferation, the three
hydroxylation sites of the protein could be mutated to prevent the hydroxylation [37].
This would allow the concentration of HIF-1α to build and cause gene transcription even
in the presence of oxygen, in this stud the oxygen insensitive form of HIF-1α is denoted
as CA-HIF-1α (Figure 4).

HIF-1α related gene knock-out
	
  

Both knock-out models and human placental studies highlight the importance of
HIF-1α during embryonic and placental development. Both HIF-1α and HIF-1β (ARNT)
knock-outs have proven to be embryo-lethal [28,42-44]. Knocking-out the von HippelLindau (VHL) gene, which is important in recognizing the hydroxylated HIF-1α to signal
it toward proteasomal degradation, leads to embryonic lethality due to defective placental
vascularization [45]. Knock-outs of PHD-2, the primary form of PHD responsible for
hydroxylation of HIF-1α, have also proven to be embryonic lethal [46]. Another gene
knock-out study of interest is the study of catechol-O-methlytransferase (COMT), an
enzyme involved in metabolism of 2-methoxyestradiol (2-ME), which is known to
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Figure 4. Oxygen insensitive form of HIF-1α, CA- HIF-1α, is always active.
(A) Schematic of how CA-HIF-1α is able to be active even in the presence of oxygen.
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Figure 4.
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suppress HIF-1α in vivo [47]. COMT knock-out mice, which have low 2-ME levels and
therefore high levels of HIF-1α, exhibit characteristics similar to pre-eclamptic women
[47]. Human placental studies also support the importance of HIF-1α regulation for
embryonic and placental development. Placentas analyzed from pre-eclamptic human
pregnancies have shown an increase in HIF-1α protein expression [30,31]. Therefore,
regulation of HIF-1α is important during embryonic development either in the embryo, in
the placenta, or both; therefore, a lack of its regulation could lead to pregnancyassociated disorders.

Summary
Correct placental formation is essential for mammalian pregnancy. Oxygen levels
in the placenta have proven to be key in regulation of placental development.
Specifically, HIF-1α has been proven to be an important regulator of trophoblast
differentiation and proliferation and looks to be important in placental development. In
this study, we prolonged the mRNA expression of placental HIF-1α, by using a form
HIF-1α, denoted as CA-HIF-1α, that is insensitive to oxygen, in order to determine its
importance in embryonic and placental development. Placental-specific, prolonged
mRNA expression of HIF-1α was achieved by lentiviral infection of embryos at the
blastocyst stage of development, allowing for stable gene expression in the placenta
without infection of the mother or fetus. Placental sections were analyzed via in situ
hybridization to analyze placental organization and development. Our results show that
placental-specific, prolonged HIF-1α expression leads to abnormal placental

14	
  

development, suggesting that regulation by HIF-1α plays a critical role in placental
formation. Therefore, deregulation of HIF-1α could lead to pregnancy associated
disorders or early termination.
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II. MATERIALS AND METHODS
Materials
The plasmid construct pc3-HIF-1α3XSDM was generously provided by Dr.
Christina Warnecke of Universität Erlangen-Nürnberg, Germany [26].

Restriction

enzymes and buffers used for ligation experiments were purchased from Invitrogen
(Carlsbad, CA). The 293FT cell line and Virapower packaging mix was purchased from
Invitrogen Corp (Carlsbad, CA). Metafectene transfection reagent was obtained from
Biontex (Planegg, Germany) The 5X PEG-it virus precipitation solution was purchased
from System Biosciences (Mountain View, CA). HIV-1 p24 Antigen ELISA 2.0 kit used
for viral titering was obtained from ZeptoMetrix Corporation (Buffalo, NY). C57Bl/6
male and female mice, ICR female mice, and vasectomized ICR male mice were
purchased from Harlan Laboratories (Indianapolis, IN) or Taconic Farms Inc.
(Germantown, NY). Pregnant Mare’s Serum gonadotropin (PMS), Human Chorionic
Gonadotropin (HCG), and mineral oil were acquired from SIGMA-Aldrich Co. (St.
Louis, MO). EmbryoMax M2 Media and EmbryoMax KSOM embryo culture media
were obtained from Millipore (Billerica, MA.) The Non-Surgical Embryo Transfer
Device (NSET) was purchased from ParaTechs Corporation (Lexington, KY).
Vectashield mounting media was obtained from Vecotor laboratories (Burlingame, CA).

Cloning and Cell Culture
In order to create the lentiviral construct (pLv) containing the HIF-1α3XSDM
gene (oxygen insensitive form of HIF-1α) under the constitutive Cytomegalovirus
16	
  

(CMV) promoter; the pc3-HIF-1α3XSDM construct and pLB2V5 (a construct generated
by replacing the Green Fluorescent Protein (GFP) gene of pLv-CMV-GFP-V5 with a
multiple cloning site) were digested using BamHI and ApaI restriction enzymes. DNA
fragments for ligation were isolated and the HIF-1α3XSDM gene was then ligated into
the pLB2V5 using the compatible BamHI and ApaI ends and T4 DNA ligase to generate
pLB2V5-CA-HIF-1α. The ligation constructs were transformed into One Shot Stbl3
Chemically Competent Cells (Invitrogen, Carlsbad, CA). Transformed constructs were
selected by ampicillin resistance (50µg/mL). DNA was isolated from bacterial cells and
the construct was confirmed by differential restriction digestion and sequencing
(Cleveland Genomics, Cleveland, OH).
293FT cells were cultured in DMEM/High glucose (Thermo Scientific, Waltham,
MA), 10% heat-inactivated fetal bovine serum (Biowest, Kansas City, MO), 1%
antibiotic-antimycotic (Thermo Scientific, Waltham, MA), 1 mM sodium pyruvate
(Mediatech, Inc., Manassas, VA), 2 mM glutaGRO Supplement (Mediatech, Inc.,
Manassas, VA), 0.1 mM NEAA Mixture (Lonza, Walkersville, MD) and 500 µg/mL
G418 (InvivoGen, San Diego, CA). Cos7 cells were cultured in DMEM/High glucose
(Thermo Scientific, Waltham, MA), 10% heat inactivated fetal bovine serum (Biowest,
Kansas City, MO), and 1% antibiotic-antimycotic (Thermo Scientific, Waltham, MA).
Rcho-1 cells were cultured as previously described [26,48]. All cell types were passaged
at 80-90% confluence.

Western blotting (Kashmira Kulkarni unpublished methods)
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Nuclear extracts for analysis of HIF-1a were completed by using CellLytic
NuCLEAR Extraction Kit following the manufacturer’s specifications.

Cells were

scraped and collected in chilled 1xPBS and followed by lysis via use of a hypotonic lysis
solution.

Nuclear extracts were isolated by treatment with specified solutions and

differential centrifugation. Proteins were used for Western blot analysis or stored at 80oC until further use. Bradford method was used to determine nuclear extract
concentration and samples were analyzed spectrophotometrically at 595nm [49]. The
concentration of protein in each sample was determined using a Bovine serum albumin
standard protein curve. Nuclear extracts (12.5-50 µg protein) were reduced using 1x
reducing sample buffer (62.5 µM Tris pH 6.8, 2% SDS, 12.5% glycerol, 2.5% Betamercaptoethanol and 0.1% of 2.5% bromophenol blue in ethanol [50]. Samples were
boiled at 95oC for 10 minutes and separated on 8%-10% SDS-polyacrylamide gel.
Precision plus protein standard dual colored markers were used to determine the
molecular weights (BioRad, Berkeley, California). Proteins separated by SDS-PAGE
electrophoresis were transferred to PVDF (polyvinylidene fluoride) membrane in transfer
buffer (25mM Tris pH 8.0, 192 mM glycine and 20% methanol overnight at 100mA
constant current [26,51]. Ponceau S staining was used to confirm protein transfer. The
membrane was incubated with blocking buffer (5% Non- fat milk, 60 mM Tris base, 204
mM NaCl, 0.025% Tween 20, pH 7.4) for 1hr at room temperature on a rocker.
Subsequently, the blot was incubated with primary antibody at 4oC overnight or 1hr at
room temperature on a rocker. The membrane was washed three times with 1x PBS
containing 0.05% Tween 20, and was incubated with secondary antibody for 1hr while
rocking. After 1hr incubation, the membrane was washed three times with 0.05% Tween
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20 in 1XPBS [26,51]. Specific protein was identified with ECL chemiluminiscence
reagent (Amersham).

Luciferase assay (Kashmira Kulkarni unpulblished methods)
To determine Hypoxia Response Element (HRE) reporter activity, cos7 cells were
transiently transfected with 0.2 µg pRL-SV40-promoter constitutive reporter plasmid,
1µg PGK1-HRE luciferase reporter plasmid, 1µg of plasmid (either pLB2V5, pLB2V5CA-HIF-1α, or pc3-HIF-1α3XSDM) and 5µl Metafectene reagent. Media was changed
18hrs post transfection. Twenty-four hours post media change, luciferase reporter activity
was determined by using the Dual Luciferase Assay system (Promega) according to the
manufacturer’s protocol. Results show the fold-increase in HRE activity in samples
cultured at ambient oxygen.

Lentiviral production
293FT cells were transfected with 9 µg of the plasmid containing the gene of
interest, either pLB2V5-CA-HIF-1α or pLv-CMV-GFP-V5, and optimized Virapower
packaging mix, including 4.6 µg pLP1, 1.8 µg pLP2, and 2.52 µg pLp-VSVG,
(Invitrogen, Carlsbad CA) using 50 µl Metafectene transfection reagent (Biontex,
Planegg, Germany).

Media was changed at 24hrs post transfection and virus was

collected at 72hrs after media change. Virus containing media was centrifuged for 20
minutes at 3,000rpm. The supernatant was stored at –80oC and later used for infection.
19	
  

Lentiviral concentration and titering
Viral supernatant was mixed with 5X PEG-it virus precipitation solution (System
Biosciences, Mountain View, CA) and incubated overnight at 4oC. The mix was then
centrifuged at 3,000 rpm for 30 min at room temperature. The supernatant was discarded
and pellet was obtained. The pellet was re-suspended in 1XPBS and Polybrene
(Millipore, Billerica, MA) at a final concentration of 10 µg/ml. The re-suspended pellet
was used for infections of blastocysts. Titering for viral concentrations was completed
with concentrated virus following manufacturer’s specifications using HIV-1 p24
Antigen ELISA 2.0 (ZeptoMetrix Corporation, Buffalo, NY).

Briefly, samples and

standards were prepared and added to pre-washed microplate.

The microplate was

covered and incubated for 3 to 24 hours at 37 oC and then washed before adding HIV-1
Detector Antibody. The microplate was covered and was incubated at 37 oC for 1 hour.
The microplate was washed, substrate was added, and incubated at room temperature for
30 min. The reaction was stopped by adding Stop Solution and plate was read within 15
min at 450 nm on a plate reader. For infection, LB2V5-CA-HIF-1α or Lv-CMV-GFP-V5
lentivirus was concentrated to a final infective concentration of 6,800 ng/ml or 1,200
ng/mL, respectively.

Blastocyst Isolation and Culture
Four to five week old (14-16 gram) C57Bl/6 female mice were super-ovulated by
injection of 5 International Units (IU) PMSg, Pregnant Mare’s Serum gonadotropin
(SIGMA-Aldrich, St. Louis, MO), and 47 hours later injected with 5IU HCG, Human
20	
  

chorionic gonadotropin (SIGMA-Aldrich, St. Louis, MO). Females were allowed to
mate with male C57Bl/6 mice immediately after HCG injection and plug checked at 0.5
days post copulation (d.p.c.). At 1.5 d.p.c., super-ovulated females were CO2 euthanized
and the oviducts were removed for 2-cell collection. The oviducts were shredded in
EmbryoMax M2 Media with phenol red for collection (Millipore, Billerica, MA).
Microdrop cultures were setup 18-24 hours before use by covering 20 µl drops of
EmbryoMax KSOM embryo culture media (Millipore, Billerica, MA) with mineral oil
(SIGMA-Aldrich, St. Louis, MO) in a 35 mm cell culture dish and incubated at 37.5oC at
5.5% CO2. Isolated embryos were placed in Microdrop culture of EmbryoMax KCL
Simplex Optimization Medium (KSOM) and incubated at 37.5oC and 5.5% CO2 until
further use.

Blastocysts infection
Concentrated virus that was re-suspended in 1XPBS and Polybrene mixture was
placed in a 35 mm plate and covered with approximately 2 ml of mineral oil to create
virus microdrop culture. Virus microdrop culture was allowed to incubate for 30 minutes
at 37.5oC and 5.5% CO2 prior to treatment of blastocysts. Blastocysts at day E3.5 were
treated with acidic Tyrode’s solution (SIGMA, St. Louis, MO), to remove the zona
pellucida, the protective protein coat that surrounds the embryo and prevents viral
infection. Blastocysts were subsequently washed three to four times in EmbryoMax M2
medium, and transferred into virus microdrop cultures and incubated for 4 to 6 hours at
37.5oC and 5.5% CO2. Post infection, blastocysts were washed in EmbryoMax M2
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embryo culture media to remove virus.

Embryos were combined into one drop of

EmbryoMax M2 medium and were used for embryo transfer.

Embryo transfer
Eight to ten week old Imprinting Control Region (ICR) mice (23-33 grams), were
allowed to mate with vasectomized ICR males overnight to produce pseudo-pregnant
females. Females were plug checked at 0.5 d.p.c., and females positive for copulation
were used for embryo transfer. Post-lentiviral infection blastocysts were washed in
EmbryoMax M2 medium and 10-20 embryos were transferred into a 2.5 d.p.c. pseudopregnant ICR mouse via an NSET Device, Non-Surgical Embryo Transfer Device
(ParaTechs Corporation, Lexington, KY).

Immunocytochemistry (Kashmira Kulkarni unpulblished methods)
Placenta and embryo sections were hydrated with 3 washes in 1xPBS for 5
minutes each. Hydration was followed by permeabilization treatment with TritonX-100
(0.2% TX-100 in 1xPBS). Permeabilization was followed by quenching with glycine
(1% in 1xPBS). Sodium borohydrate (NaBH4 0.1% in 1xPBS) treatment for was used to
quench autoflourescence. The tissues were then blocked in blocking solution (Goat
serum 10%, tween 0.05% in 1xPBS) for 1hr at room temperature. Primary antibody (V5topo at 1:500) was applied overnight in 1% blocking solution at 4oC overnight in a
humidified chamber.

The following day sections were washed with 1xPBS and
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secondary antibody (Alexa Fluor 594 Goat anti rabbit, at 1:1000) was applied in 1%
blocking solution for 1hr at room temperature in a dark box. Sections were washed with
1xPBS and treated with Hoeschst stain (1ug/ml) for 5 minutes at room temperature
followed by 3 washes with PBS. Using Vectashield mounting media, glass cover slips
were mounted on the plate surface, and staining was observed by fluorescence
microscopy.

Probes
Digoxigenin (DIG)-labeled riboprobes were prepared according to the
manufacturers protocol (Roche) (Figure 5). Riboprobes for Pcdh12, Tpbpa, Gcm1,
Prl3b1/Pl2, Prl2c2/Plf, and Ascl2/Mash2 have been previously described (Table 1)
[16,17, 19,52-56]. Riboprobes for Pecam-1 were generated from a plasmid that was
created in the lab. Briefly, PCR was used to amplify an 811 base pair region
corresponding to nucleotides 1784 to 2595 of the Pecam-1 messenger RNA sequence
(NM008816). This fragment was subsequently cloned into pGEM-Teasy (Promega). For
detection of Hif1a, riboprobe template was amplified by RT-PCR utilizing forward and
reverse primers incorporating T3 and T7 RNA polymerase recognition sites, respectively.
The primer sequences were: Forward/T3, 5’AATTAACCCTCACTAAAGGGCAGTCGACACAGCCTCGATA,
Reverse/T7, 5’-TAATACGACTCACTATAGGGTTTGGAGTTTCCGATGAAGG and
amplify an amplicon of approximately 670 bp.
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Tissue preparation and in situ hybridization
Conceptuses for in situ hybridization were dissected at E14.5 in cold 1xPBS after CO2
asphyxiation, fixed overnight in 4% paraformaldehyde (PFA) in 1XPBS at 4°C,
embedded in paraffin and sectioned (7 µm) as previously described [53,57]. For in situ
hybridization, sections underwent de-paraffinization in xylene followed by rehydration
through a graded ethanol series ending in PBS. Sections were then post-fixed in 4%
PFA, treated with proteinase K to degrade protein and reduce background (15 mg/ml for
5 minutes at room temperature). Then, sections were acetylated for 10 minutes (acetic
anhydride, 0.25%; Sigma) and hybridized with DIG-labeled probes overnight at 65oC.
Hybridization buffer contained 1X salts (200mM NaCl, 13 mM Tris, 5 mM sodium
phosphate monobasic, 5 mM sodium phosphate dibasic, 5 mM EDTA), 50% formamide,
10% (w/v) dextran sulfate, 1 mg/ml yeast tRNA (Sigma), 1X Denhardt’s [1% (w/v)
bovine serum albumin, 1% (w/v) Ficoll, 1% (w/v) polyvinylpyrolidine) and cRNA probe
(final dilution of 1:2000 from reaction with 1 mg template DNA). Post-hybridization
washes were followed by an RNase treatment [400 mM NaCl, 10mM Tris (pH 7.5), 5
mM EDTA, 20 mg/ml RNase A]. After blocking with blocking solution (hybridization
buffer lacking cRNA probe), sections were incubated overnight at 4oC in alkaline
phosphatase-conjugated, anti-DIG antibody (Sigma) diluted 1:2500 in blocking solution.
Sections were washed and signals were detected using alkaline phosphatase
immunohistochemistry with nitro-blue tetrazolium chloride and 5-bromo-4-chloro-3'indolyphosphate p-toluidine salt (NBT/BCIP) as the substrate as previously described
[53,58]. Sections were counterstained with nuclear fast red.
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Figure 5. Diagram of a riboprobe.
Schematic of how in situ hybridization works via use of a DIG-labeled riboprobe.
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Figure 5.
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Table 1. Genes surveyed by in situ hybridization.

Marker Name
Hypoxia inducible
factor 1 alpha
Mammalian achaetescute homologous
protein-2
Glial cell marker-1
Trophoblast specific
protein alpha
Protocadherin-12
Placental lactogen II
Platelet/endothelial
cell adhesion
molecule-1
Proliferin

Marker
Abbreviation

Cell Type Marked

Marker
Citation

HIF-1α

N/A

Mash2
Gcm-1

Progenitor cells
Labyrinthine progenitors

[19]
[16]

Tbpba
Pcdh12
Pl2

Spongiotrophoblasts
Glycogen cells
Non-invasive giant cells

Pecam-1
Plf

Maternal endothelial cells
Invasive giant cells

[52]
[53]
[53]
Natale
(unpublished
data)
[54]
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Current Study

Animal use
	
  

All animal procedures were performed in accordance with the Wright State University
Laboratory Animal Care and Use Committee (LACUC).
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III. RESULTS

Placental specific expression
	
  
Previous studies have shown the ability to obtain placental specific gene
expression via infection at the blastocyst stage, embryonic day 3.5 (E3.5) [11,13].
Infection at the blastocyst stage allows for placental-specific gene transfer because the
embryo consists of two cell types, the ICM, which gives rise to the fetus and the
trophectoderm, the single-cell outer layer which gives rise to the placenta [10-13].
Lentiviral infection and then embryo transfer at this stage allows for gene expression in
the placenta without the mother or fetus expressing the gene of interest [11,13].
Following this method, we infected blastocysts with Lv-CMV-GFP-V5 virus, which used
GFP as a reporter gene. We confirmed lentiviral infection of the blastocyst via
fluorescent microscopy to detect GFP expression (Figure 6). In order to confirm that the
infection was placental specific, fetoplacental units were collected at E10.5 and were
visualized for GFP expression via fluorescent microscopy. Only the placenta (P) showed
GFP expression, but the decidua (D), maternal tissue, of the mother and the embryo (E)
lacked GFP expression (Kashmira Kulkarni, unpublished data, Figure 7). Placental
transduction by Lv-CMV-GFP-V5 was confirmed by expression of both GFP and V5
epitope tag since the V5 epitope is located at the end of the GFP reading frame and is
followed by a stop codon (Kashmira Kulkarni, unpublished data, Figure 8A). While GFP
expression was observed by fluorescent microscopy (Figure 8C), V5 epitope expression
(red) was observed throughout the GFP expressing placenta by immunocytochemical
analysis (Figure 8D) and co-localization of the GFP expression and V5 staining was
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Figure 6. Trophoblast specific GFP expression after infection with Lv-CMV-GFPV5 at the blastocyst stage.
Mouse blastocyst (E3.5) devoid of zona pellucida was infected with concentrated LvCMV-GFP-V5 virus for 4-6 hours at 37.5oC and 5.5% CO2. (A) The bright field image
of a post infection. (B) GFP expression was assessed post infection via fluorescent
microscopy.
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Figure 6.
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Figure 7. Analysis for placental specific expression of the GFP at E10.5 after
infection with Lv-CMV-GFP-V5 at the blastocyst (E3.5) stage of development.
Mouse blastocyst (E3.5) devoid of zona pellucida was infected with concentrated LvCMV-GFP-V5 and transferred into pseudo-pregnant mother. Feto-placental unit was
collected at E10.5 and was fixed in 4% paraformaldehyde and embedded in O.C.T. Eight
micron sections were examined for GFP expression via fluorescent microscopy. E
indicates the embryo, P indicates the placenta, and D indicates the maternal decidua. (A)
Bright field image of the feto-placental unit, (B) fluorescent image to analyze GFP
expression, (C) overlay of bright field and fluorescent images from A and B.
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Figure 8. Immunohistochemical analysis of V5 epitope tag expression in placenta
infected with Lv-CMV-GFP-V5 virus.
Placentas were obtained on embryonic day 12.5 (E12.5) from blastocysts infected with
concentrated Lv-CMV-GFP-V5. Tissues were fixed in paraformaldehyde and embedded
in O.C.T. Eight micron sections were examined for V5 epitope tag expression by
immunocytochemistry analysis. (A) Diagram of Lv-CMV-GFP-V5 construct depicting
position of V5 epitope tag. (B) Bright field image of placenta. (C) Fluorescent
microscopy image of GFP expression. (D) Alexa Fluor 594 secondary antibodies were
used to probe for polyclonal antibodies specific to V5 epitope (red). (E) Overlay of
images C and D, where yellow color identifies overlap of GFP expression (green) and V5
staining (red). (F) Hoechst staining (blue) was performed for nuclear staining on GFP
sections stained with anti-V5 epitope tag.
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observed in the pLv-CMV-GFP-V5 infected placenta (Figure 8E). Additionally, Hoechst
staining was performed for the visualization of nuclei (Figure 8F).

HIF-1α prolonged expression
	
  
In order to cause prolonged expression of HIF-1α, we generated a lentiviral-based
plasmid, denoted as pLB2V5-CA-HIF-1α, encoding HIF-1α protein that is no longer
oxygen sensitive due to mutations of amino acids that prevent its hydroxylation and
signaling toward proteasomal degradation (Figure 9A) [37]. Western blot analysis was
performed on Rcho-1 cells transiently transfected with pLv-CMV-GFP-V5, pLB2V5CA-HIF-1α, or pc3-HIF-1alpha3XSDM (positive control). Western analysis confirmed
increased HIF-1α protein expression by newly formed pLB2V5-CA-HIF-1α construct
under ambient oxygen (Figure 9B). To test the ability to bind the hypoxia response
element (HRE) that allows for transcriptional activation, the newly formed pLB2V5-CAHIF-1α and the base plasmids of pLB2V5 (lentiviral backbone) and pc3-HIF1alpha3XSDM (plasmid containing oxygen independent HIF-1α) were transiently
transfected into Cos7 cells. The pLB2V5-CA-HIF-1α and base plasmid pc3-HIF1alpha3XSDM resulted in activation of the phosphoglycerate kinase-hypoxia responsive
element- luciferase reporter (PGK-HRE-luciferase), indicating that CA-HIF-1α was able
to bind the hypoxia response element under ambient oxygen conditions (Figure 9C).
Prolonged expression of CA-HIF-1α in vivo was verified via in situ hybridization
using a HIF-1α riboprobe. Blastocysts, devoid of zona pellucida, infected with either LvCMV-GFP-V5 or LB2V5-CA-HIF-1α and transferred into pseudo-pregnant mothers and
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Figure 9. HIF-1α3XSDM gene was cloned into lentiviral vector and in situ
hybridization analysis for prolonged expression of HIF-1α.
HIF-1alpha3XSDM gene was excised from pc3-HIF-1α3XSDM plasmid and ligated into
pLB2V5 plasmid using BamHI and ApaI restriction enzymes. (A) Diagram of newly
formed pLB2V5-CA-HIF-1α plasmid construct, which was confirmed by sequencing.
Rcho-1 cell were transiently transfected with pLv-CMV-GFP-V5, pLB2V5-CA-HIF-1α,
or pc3-HIF-1alpha3XSDM and Western blot analysis was completed to confirm
expression of HIF-1α protein at ambient oxygen (B). Cos7 cells were transiently
transfected with pLB2V5, pLB2V5-CA-HIF-1α, or pc3-HIF-1alpha3XSDM and HIF1alpha expression was analyzed under ambient oxygen conditions and PGK-1-HRE
reporter activity was determined using Luciferase reporter assay (C). (D) Placentas from
either LB2V5-CA-HIF-1α (right panel) or Lv-CMV-GFP-V5 control (left panel) infected
blastocysts were collected at embryonic day 14.5 (E14.5) and fixed in paraformaldehyde
and embedded in paraffin. Placental sections were hybridized with DIG-labeled
riboprobes specific for HIF-1α, denoted by purple staining. DIG-expression was
analyzed using alkaline phosphatase immunohistochemistry. Sections were
counterstained with nuclear fast red.
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fetuses and placentas were collected at E14.5 for analysis. Placentas infected with
LB2V5-CA-HIF-1α (Figure 4B, right) showed much greater HIF-1α expression than
those infected with Lv-CMV-GFP-V5 control virus (Figure 9D, left), proving that
infection with LB2V5-CA-HIF-1α does prolong the expression of HIF-1α.
To test the functionality of placentas that have prolonged expression of HIF-1α,
placental and fetal weights were measured at E14.5 and the placental tissue was analyzed.
When comparing both placental and fetal weights of pregnancies from blastocysts
infected with control Lv-CMV-GFP-V5 virus or LB2V5-CA-HIF-1α, there is no
significant difference in the placental or fetal weights at E14.5 (Figure 10). However,
placental analysis via in situ hybridization exhibited a drastic change in placental
morphology.

Inhibition of differentiation
	
  

Prolonged expression of HIF-1α showed a tendency for cells to remain in progenitor
states. Progenitor cell distribution was analyzed by in situ hybridization of Mash 2
(Figure 11). Mash 2 expression is greatly increased in placentas exhibiting prolonged
HIF-1α (Figure 11, right) compared to control placentas expressing GFP (Figure 11, left).
This evidence shows that prolonged placental HIF-1α is inhibiting trophoblasts from
progressing past progenitor cells states. Specific glycogen cell distribution was analyzed
via Pcdh12 (Figure 1). Generally, the prolonged expression HIF-1α placentas (Figure 11,
right) showed less organization of glycogen cells when compared to control placentas,
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Figure 10. Prolonged HIF-1α gene expression does not affect fetal or placental
weight at E14.5 stage in development.
Mouse blastocyst (E3.5) was infected with concentrated pLv-CMV-GFP-V5 or pLB2V5CA-HIF-1α and transferred into pseudo-pregnant mother. Placentas and fetuses from
either pLB2V5-CA-HIF-1α (n= 11 fetuses and placentas) or pLv-CMV-GFP-V5 (n= 7
fetuses and placentas) infected blastocysts were collected at embryonic day 14.5 (E14.5)
and weighed immediately after dissection.

40	
  

Figure 10.
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Figure 11. Prolonged HIF-1α gene expression inhibits placental cells from
progressing past their progenitor states.
Placentas and fetuses from either LB2V5-CA-HIF-1α (right) or Lv-CMV-GFP-V5 (left)
infected blastocysts were collected at embryonic day 14.5 (E14.5) and fixed in
paraformaldehyde and embedded in paraffin. Placental sections were hybridized with
DIG-labeled riboprobes specific for Mash 2 (progenitor cell marker) or Pcdh12
(glycogen cell marker), denoted by purple staining. DIG-expression was analyzed using
alkaline phosphatase immunohistochemistry. Sections were counterstained with nuclear
fast red. Brackets indicate areas with organized glycogen cells.
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which had organized glycogen cells (indicated by brackets) (Figure 11, left). These data
indicate a lack of timely and proper differentiation as well as placental disorganization.
Decrease in branching morphogenesis
	
  

Analysis of the labrynthine layer was determined by in situ hybridization for
Gcm-1 (Figure 12). Upon viewing a gross section of the placentas, Gcm-1 expression in
the HIF-1α placentas is less prevalent and more disorganized than in control placentas
(Figure 12). Upon further investigation at higher magnification, punctate expression
(indicated by arrows) of Gcm-1 was observed in the labrynthine layer of HIF-1α
placentas, where as a normal banding and distributed expression of Gcm-1 (indicated by
brackets) was seen in the control placentas shown by brackets (Figure 12, bottom).
Disorganization and limited, punctate expression of Gcm-1 is indicative of a lack of
branching morphogenesis, as shown by arrows (Figure 12, bottom).

Placental disorganization
	
  

To analyze the organization of the spongiotrophoblasts, in situ hybridization for Tpbpa
was assessed. In CA-HIF-1α placentas, the spongiotrophoblast layer is compact and
cells in this layer have much less Tpbpa expression in comparison to control placentas
(Figure 13). These data suggest disorganization of the placenta as a whole and decrease
in trophoblast stem cells.
Since the spongiotrophoblast layer suggests placental disorganization, the giant cell layer
was also analyzed via in situ hybridization for Pl2 (Figure 13). The number of giant cells
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Figure 12. Prolonged HIF-1α gene expression decreases branching morphogenesis.
Placentas and fetuses from either LB2V5-CA-HIF-1α (right) or Lv-CMV-GFP-V5 (left)
infected blastocysts were collected at embryonic day 14.5 (E14.5) and fixed in
paraformaldehyde and embedded in paraffin. Placental sections were hybridized with
DIG-labeled riboprobes specific for Gcm-1 (lineage specific labyrinthine cell marker for
branching morphogenesis), denoted by purple staining. DIG-expression was analyzed
using alkaline phosphatase immunohistochemistry. Sections were counterstained with
nuclear fast red. (Top) Gcm-1 at 4X magnification. (Bottom) Gcm-1 at 20X
magnification with brackets indicating banding, distributed expression and arrows
indicating punctate expression.
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Figure 13. Prolonged HIF-1α gene expression decreases placental organization.
Placentas and fetuses from either LB2V5-CA-HIF-1α (right) or Lv-CMV-GFP-V5 (left)
infected blastocysts were collected at embryonic day 14.5 (E14.5) and fixed in
paraformaldehyde and embedded in paraffin. Placental sections were hybridized with
DIG-labeled riboprobes specific for Tpbpa (lineage specific spongiotrophoblasts cell
marker) or Pl2 (lineage specific giant cell marker), denoted by purple staining. DIGexpression was analyzed using alkaline phosphatase immunohistochemistry. Sections
were counterstained with nuclear fast red.
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in the HIF-1α placentas (Figure 13, right) was greatly increased when compared to the
control placentas. In addition to the increase in giant cells in the HIF-1α placentas, the
giant cells were located in areas of the placenta that predominantly contain labrynthine
cells and very few giant cells, as seen in the control placenta (Figure 13, left). The
increase in giant cells and lack of spongiotrophoblasts may be due to a shuttling of the
spongiotrophoblasts stem cells into the giant cell lineage. Together, the giant cell layer
and spongiotrophoblast layer demonstrate the lack of organization apparent in the
placentas with prolonged mRNA expression of HIF-1α (Figure 13).
Decrease in maternal artery remodeling
	
  

After disorganization of the giant cell layer was confirmed, the functionality of
the giant cells was investigated. In order to determine if invasive giant cells were
functioning normally and remodeling the maternal arteries, which is an essential step in
appropriate placental and embryonic development, placentas were analyzed via in situ
hybridization for Pecam-1 (maternal endothelial cell marker), which marks maternal
endothelial cells [8,59]. Cells surrounding the maternal arteries (indicated by arrows) in
HIF-1α placentas show considerably more Pecam-1 expression than control placentas,
which show very little expression surrounding maternal arteries (Figure 14). The greater
expression in HIF-1α placentas suggests a lack of maternal remodeling, but to further
investigate maternal remodeling, placentas were analyzed for Plf expression, which
indicates the presence of invasive giant cells, and is a gene that is not directly under HIF1α regulation [28].

Placentas with prolonged HIF-1α (Figure 14, right) reveal a lack in

Plf expression surrounding maternal arteries (cells surrounding arteries are indicated by
arrows), where control mice (Figure 14, left) exhibited robust Plf expression surrounding
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Figure 14. Prolonged HIF-1α gene expression prevents maternal artery remodeling.
Placentas and fetuses from either LB2V5-CA-HIF-1α (right) or Lv-CMV-GFP-V5 (left)
infected blastocysts were collected at embryonic day 14.5 (E14.5) and fixed in
paraformaldehyde and embedded in paraffin. Placental sections were hybridized with
DIG-labeled riboprobes specific for Pecam-1 (maternal endothelial cell marker) or Plf
(specific invasive giant cell marker), denoted by purple staining. DIG-expression was
analyzed using alkaline phosphatase immunohistochemistry. Sections were
counterstained with nuclear fast red. Arrows indicate tissue surrounding maternal
arteries.
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maternal arteries (Figure 14). The presence of maternal endothelial cells, along with the
lack of invasive giant cells clearly illustrate that placentas with prolonged HIF-1α
expression fail to remodel maternal arteries. Thus, indicating HIF-1α as a major regulator
of maternal artery remodeling and placental development.
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IV. DISCUSSION
Altered Morphology
	
  

Embryonic development occurs under low oxygen levels, and under low oxygen
levels of HIF-1α are greater due to an increase in HIF-1α half-life. During implantation,
access to oxygen via the maternal blood supply causes a decrease in HIF-1α, due to a
rapid proteasomal degradation (half-life of approximately 5 minutes) [60,61]. The access
to oxygen resulting in a decrease in HIF-1α expression is believed to be what determines
the nature of trophoblast cells in terms of proliferation versus differentiation [24,25].
Therefore, HIF-1α regulation would directly effect placental development.
Our study suggests that prolonged HIF-1α expression dramatically alters placental
morphology and possibly function by preventing differentiation into fully functioning
trophoblast cells. Trophoblast cells of placentas with prolonged expression of HIF-1α
exhibit disorganization with numerous giant cells being expressed in the labyrinthine
layer and compaction of the spongiotrophoblast layer.

Disorganization was also

demonstrated by a decrease in branching morphogenesis of the labrynthine layer, which
is responsible for nutrient transport [62].

Although this disorganization did not

demonstrate a significant difference in placental or fetal weight at this stage of
development (Figure 5), the difference in fetal and placental size may be more
pronounced if carried out until birth.

One explanation for having no significant

difference in fetal weights at E14.5 is that the placental invasion of maternal arteries had
just completed, placental invasion is completed near E12 in mice [23]. Placental invasion
of maternal arteries is key in placental development and determining whether a
pregnancy will be successful; therefore, it may be expected that differences in pup weight
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may not be apparent until later in the pregnancy, after the fetus has had time to fully
develop [4,9].

Maternal artery remodeling
	
  

The results of this study indicated a notable inability of invasive giant cells to
remodel maternal arteries. The lack of invasive giant cell function was seen by both the
presence of maternal endothelial cells surrounding arteries and a lack of invasive giant
cells that should have replaced the maternal endothelial cells through the process of
remodeling. Remodeling of maternal arteries is mediated by invasive trophoblast giant
cells that destroy maternal endothelial cells and replace them with endovascular
trophoblast cells [9]. Pre-eclampsia is a disorder that effects approximately 5-7% of all
pregnancies and is believed to result from inappropriate trophoblast invasion and
remodeling of maternal arteries, as we have seen in this study [2,7,59,52,63]. However,
the exact cause of pre-eclampsia has yet to be elucidated. It is known that pre-eclampsia
is characterized by the symptoms of high blood pressure and proteinuria during
pregnancy, which can result in early delivery, and possible maternal and/or fetal mortality
[6,7,64]. Vascular tension caused by overexpression of HIF-1α in the placenta during
pregnancy may be one explanation for the increased blood pressure experienced by those
who have pre-eclampsia. It also follows that proteinuria is a result of this increased
vascular tension that would also effect the kidneys and their function. Understanding the
role of HIF-1α regulation in placental development could aid in our understanding preeclampsia as a whole.
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Future studies
	
  

Although this study provides evidence for the importance of regulation of HIF-1α
expression to maintain placental organization and function of certain cell types, further
studies must be completed in order to determine the effects of prolonged HIF-1α
expression at birth. In order to confirm that the placenta is not plastic in nature, placentas
would need to be collected at birth. Additionally, placental and pup weights would be
taken at birth to determine if pups are small in comparison to controls because a decrease
in birth weight is indicative of pre-eclampsia and other pregnancy associated disorders
[6,7,47,64]. Another important aspect of many pregnancy-associated disorders is early
delivery. In order to determine if prolonged expression of HIF-1α causes early pup
delivery, the time and embryonic day of delivery would need to be recorded. In addition
to examining birth weight, placental weight, and time of birth, additional factors that are
common in pre-eclampsia could be studied. Since pre-eclampsia is known for a lack of
maternal spiral artery remodeling, as was evident in this study at E14.5, the additional
symptoms of pre-eclampsia should be analyzed [6,7,9,63,64]. These include high
maternal blood pressure, maternal proteinuria, circulating maternal soluble fms-like
tyrosine kinase 1 (sFlt1), and glomerular injury [6,7,63-67]. Maternal blood pressure,
protein levels, and sFlt1 would need to be tested before embryonic implantation, during
pregnancy, and post birth.

These points are all necessary because women who

experience pre-eclampsia usually exhibit normal blood pressure, low to no urine protein,
and normal sFlt1 before or after birth, but display increased blood pressure and sFlt1
levels, as well as proteinuria during pregnancy [6,7,47,64]. Since sFlt-1 is a direct target
of HIF-1α, it would be expected that sFlt-1 levels would rise in our mice [63,65].
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Maternal kidneys collected at birth could be used to test for glomerular injury. Since
there is proteinuria in pre-eclampsia, some glomerular injury would be expected. [6, 65]
In a very extreme case of pre-eclampsia known as hemolysis, elevated liver enzymes, and
low platelets (HELLP) syndrome mothers experience extensive glomerular injury.
Checking maternal kidneys would therefore be beneficial in identifying the severity of
pre-eclampsia.
Another study that would better elucidate the role of HIF-1α during placental
development would include causing increased HIF-1α during specific time-points during
placental development. This study could be completed by cloning the oxygen insensitive
form of HIF-1α used in this study into a lentiviral, tet-inducible construct. The placenta
would be infected in the same manner as in this study; however, the increased expression
of HIF-1α would not be induced until addition of doxycycline to the system. By this
method of analysis, the critical time-points of placental development governed by HIF-1α
could be determined. This method could even allow for increase expression of HIF-1α
only during the initial development of the placenta, around E9.5-11.5, followed by
normal HIF-1α expression throughout the rest of the pregnancy. The ability to narrow
the window of HIF-1α increased expression could greatly increase our understanding of
the role of HIF-1α on placental development and pregnancy associated disorders.

56	
  

V. APPENDIX
	
  

Abbreviations

2-ME-2-methoxyoestradiol
ARNT: Aryl hydrocarbon receptor nuclear translocator
CA-HIF: Constitutively active- hypoxia inducible factor
CMV: Cytomegalovirus
COMT: cathechol-O-methyltransferase
DIG-Digoxigenin
d.p.c: days post copulation
E14.5: embryonic day 14.5
FIH: factor inhibiting HIF-1α
Gcm1: glial cell marker 1
GFP: Green Fluorescent Protein
HELLP: hemolysis, elevated liver enzymes, and low platelets
HIF-1α: hypoxia inducible factor 1 alpha
HIF-1β: Hypoxia inducible factor-1β
HRE: Hypoxia responsive element
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ICM: inner cell mass
ICR: imprinting control region
IU: international units
KO: Knock out
KSOM: KCL Simplex Optimization Medium
Mash2: Mammalian achaete-scute homologous protein-2
NBT/BCIP: nitro-blue tetrazolium chloride and BCIP 5-bromo-4-chloro-3'
indolyphosphate p-toluidine salt
Pecam-1: platelet/endothelial cell adhesion molecule-1
PHD: prolyl hydroxylase domain protein
PBS: phosphate buffered saline
PFA: paraformaldehyde
PL2: Placental lactogen II
Plf: proliferin
PlGF: placental growth factor
pLv: Lentiviral plasmid
PVDF: polyvinylidene fluoride

sFlt1: soluble fms-like tyrosine kinase 1
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Tpbpa/ 4311: Trophoblast specific protein alpha
VEGF: vascular endothelial growth factor
VHL: von Hippel-Lindau protein
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